Fund Holdings — Artia Global Partners LP

Total Portfolio Value:
$407.68M
Total Bought:
$124.18M
Total Sold:
$18.04M
Net Transaction:
+$106.14M
Notable People:
Onusa Nmn Chantanapongwanij, Artia Global Partners Gp Llc
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Novo Nordisk A/SADR(NVO)721,507691,743-29,764$74.64M$88.82M21.79%+$14.18M
Eli Lilly and Company(LLY)92,59392,5930$53.97M$72.03M17.67%+$18.06M
Merck & Co., Inc.(MRK)329,200379,200+50,000$35.89M$50.04M12.27%+$14.15M
Viking Therapeutics, Inc.(VKTX)383,580433,580+50,000$7.14M$35.55M8.72%+$28.42M
AbbVie Inc.(ABBV)90,82190,8210$14.07M$16.54M4.06%+$2.46M
Intra-Cellular Therapies Inc41,600210,096+168,496$2.98M$14.54M3.57%+$11.56M
argenx SEADR(ARGX)34,23834,2380$13.03M$13.48M3.31%+$455.0K
AstraZeneca PLCADR(AZN)190,752190,7520$12.85M$12.92M3.17%+$76.3K
Vertex Pharmaceuticals Incorporated(VRTX)028,900+28,900$0$12.08M2.96%+$12.08M
Axsome Therapeutics, Inc.(AXSM)87,84887,8480$6.99M$7.01M1.72%+$18.4K
Ocular Therapeutix, Inc.(OCUL)440,000724,685+284,685$1.96M$6.59M1.62%+$4.63M
Cytokinetics, Incorporated(CYTK)32,11389,525+57,412$2.68M$6.28M1.54%+$3.60M
Neurocrine Biosciences, Inc.(NBIX)45,00045,0000$5.93M$6.21M1.52%+$277.2K
Disc Medicine, Inc.(IRON)087,040+87,040$0$5.42M1.33%+$5.42M
Vaxcyte, Inc.(PCVX)38,55576,255+37,700$2.42M$5.21M1.28%+$2.79M
Apogee Therapeutics Inc10,38161,590+51,209$290.0K$4.09M1.00%+$3.80M
Crinetics Pharmaceuticals In085,765+85,765$0$4.01M0.98%+$4.01M
Protagonist Therapeutics Inc112,340124,440+12,100$2.58M$3.60M0.88%+$1.02M
Dyne Therapeutics, Inc.(DYN)0119,488+119,488$0$3.39M0.83%+$3.39M
Insmed Incorporated(INSM)74,936118,236+43,300$2.32M$3.21M0.79%+$885.5K
Springworks Therapeutics Inc053,930+53,930$0$2.65M0.65%+$2.65M
Ascendis Pharma A/SADR(ASND)015,894+15,894$0$2.40M0.59%+$2.40M
IDEAYA Biosciences, Inc.(IDYA)052,492+52,492$0$2.30M0.56%+$2.30M
Merus N V050,171+50,171$0$2.26M0.55%+$2.26M
Verona Pharma PlcADS130,790130,7900$2.60M$2.10M0.52%-$495.7K
Alpine Immune Sciences Inc051,714+51,714$0$2.05M0.50%+$2.05M
Charles River Laboratories International, Inc.(CRL)6,9056,9050$1.63M$1.87M0.46%+$238.6K
Janux Therapeutics, Inc.(JANX)047,949+47,949$0$1.81M0.44%+$1.81M
Soleno Therapeutics Inc040,924+40,924$0$1.75M0.43%+$1.75M
Xenon Pharmaceuticals Inc.(XENE)040,000+40,000$0$1.72M0.42%+$1.72M
Arvinas, Inc.(ARVN)040,000+40,000$0$1.65M0.41%+$1.65M
Pliant Therapeutics, Inc.(PLRX)100,000100,0000$1.81M$1.49M0.37%-$321.0K
Mereo BioPharma Group plcADS(MREO)0421,359+421,359$0$1.39M0.34%+$1.39M
Newamsterdam Pharma Company
ORDINARY SHARES
054,285+54,285$0$1.28M0.31%+$1.28M
Rapt Therapeutics Inc19,638137,308+117,670$488.0K$1.23M0.30%+$745.0K
Silence Therapeutics plcADS(SLN)052,476+52,476$0$1.13M0.28%+$1.13M
EyePoint, Inc.(EYPT)50,00051,500+1,500$1.16M$1.06M0.26%-$91.0K
Annexon, Inc.(ANNX)0147,485+147,485$0$1.06M0.26%+$1.06M
Vera Therapeutics, Inc.CL A(VERA)024,298+24,298$0$1.05M0.26%+$1.05M
MacroGenics, Inc.(MGNX)064,007+64,007$0$942.2K0.23%+$942.2K
Kura Oncology, Inc.(KURA)039,478+39,478$0$842.1K0.21%+$842.1K
Immunovant, Inc.(IMVT)21,39721,3970$901.5K$691.3K0.17%-$210.1K
Biomea Fusion, Inc.(BMEA)25,45235,452+10,000$369.6K$530.0K0.13%+$160.4K
Larimar Therapeutics, Inc.(LRMR)058,190+58,190$0$441.7K0.11%+$441.7K
Madrigal Pharmaceuticals, Inc.(MDGL)01,557+1,557$0$415.8K0.10%+$415.8K
Poseida Therapeutics Inc086,002+86,002$0$274.3K0.07%+$274.3K
Gritstone Bio Inc95,17095,1700$194.1K$244.6K0.06%+$50.4K
BioMarin Pharmaceutical Inc.(BMRN)28,8850-28,885$2.79M$0—-$2.79M
Tyra Biosciences, Inc.(TYRA)10,2530-10,253$142.0K$0—-$142.0K
Waters Corporation(WAT)2,8450-2,845$936.7K$0—-$936.7K
Page 1 of 1
Artia Global Partners LP — 13F Holdings — Q1 2024 | TickerTrail